Iyer, V., Slivicki, R. A., Thomaz, A. C., Crystal, J. D., Mackie, K., & Hohmann, A. G. (2020). The cannabinoid CB(2) receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence. Eur J Pharmacol.

Iyer, Vishakh, Richard A. Slivicki, Ana C. Thomaz, Jonathon D. Crystal, Ken Mackie, et Andrea G. Hohmann. "The Cannabinoid CB(2) Receptor Agonist LY2828360 Synergizes With Morphine to Suppress Neuropathic Nociception and Attenuates Morphine Reward and Physical Dependence." Eur J Pharmacol 2020.

Iyer, Vishakh, et al. "The Cannabinoid CB(2) Receptor Agonist LY2828360 Synergizes With Morphine to Suppress Neuropathic Nociception and Attenuates Morphine Reward and Physical Dependence." Eur J Pharmacol 2020.